Bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) for multidrug- or rifampin-resistant tuberculosis: a systematic review

Bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) for multidrug- or rifampin-resistant tuberculosis: a systematic review

ABSTRACT Objective: To evaluate the available evidence comparing the use of the bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) regimen for 6 months with that of standard-of-care regimens for patients with multidrug-resistant or rifampin-resistant tuberculosis (MDR/RR-TB). Methods: Th...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Denise Rossato Silva, Flávia Fonseca Fernandes, Juliana Carvalho Ferreira, Wanderley Bernando, Margareth Maria Pretti Dalcolmo, Fernanda Dockhorn Costa Johansen, Fernanda Carvalho de Queiroz Mello
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Sociedade Brasileira de Pneumologia e Tisiologia 2025-01-01
Saila:Jornal Brasileiro de Pneumologia
Gaiak:
Tuberculosis, multidrug-resistant
Antitubercular agents
Diarylquinolines
Linezolid
Moxifloxacin
Nitroimidazoles
Sarrera elektronikoa:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132024000601500&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132024000601500&lng=en&tlng=en

Antzeko izenburuak